2021
DOI: 10.12701/yujm.2020.00759
|View full text |Cite
|
Sign up to set email alerts
|

Pancreatic metastasis from malignant phyllodes tumor of the breast

Abstract: Phyllodes tumors (PTs) are rare fibroepithelial neoplasms of the breast that account for 0.3% to 1% of all breast neoplasms [1]. PTs can be classified as benign, borderline, or malignant based on their histologic characteristics [2]. Malignant PTs have greater risk of distant metastasis than benign PTs. Distant metastases occur in 10% to 20% of patients with malignant PTs [2,3]. The lungs and bones are the most common sites of metastases via hematogenous spread [1,4]. The pancreas is an unusual site for metast… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 13 publications
0
2
0
Order By: Relevance
“…Recurrence is positively associated with tumour malignancy, with benign, borderline and malignant recurrence rates of 6%–9%, 11%–16% and 14%–21%, respectively 5 . Metastases can occur in the lungs, bones, pleura and pancreas, which may have fatal effects on patients 6–8 . Furthermore, morphologically similar tumour cells can exhibit different behaviours, outcomes and responses to treatment.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Recurrence is positively associated with tumour malignancy, with benign, borderline and malignant recurrence rates of 6%–9%, 11%–16% and 14%–21%, respectively 5 . Metastases can occur in the lungs, bones, pleura and pancreas, which may have fatal effects on patients 6–8 . Furthermore, morphologically similar tumour cells can exhibit different behaviours, outcomes and responses to treatment.…”
Section: Introductionmentioning
confidence: 99%
“… 5 Metastases can occur in the lungs, bones, pleura and pancreas, which may have fatal effects on patients. 6 , 7 , 8 Furthermore, morphologically similar tumour cells can exhibit different behaviours, outcomes and responses to treatment. The lack of understanding of the inherent heterogeneity of breast PTs renders the assessment of malignant behaviour and growth trend of tumour cells in clinical practice difficult.…”
Section: Introductionmentioning
confidence: 99%